Login / Signup

Lenalidomide-mediated erythroid improvement in non-del(5q) myelodysplastic syndromes is associated with bone marrow immuno-remodeling.

G KerdivelV ChesnaisE BechtA TomaN CagnardF DumontA RousseauP FenauxS ChevretN ChapuisV BoevaW H FridmanMichaela FontenayO Kosmider
Published in: Leukemia (2017)
Keyphrases
  • bone marrow
  • multiple myeloma
  • mesenchymal stem cells
  • newly diagnosed
  • stem cell transplantation
  • chronic lymphocytic leukemia
  • low dose
  • high dose